| NCT ID | NCT06603597 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Priyanka Sharma |
| Condition | HER2 + Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-09-27 |
| Primary Completion | 2044-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-09-27 with a primary completion date of 2044-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Eligibility Criteria
Inclusion Criteria: * Stage I-IV HER2-positive breast cancer Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06603597 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HER2 + Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06603597 currently recruiting?
Yes, NCT06603597 is actively recruiting participants. Contact the research team at PRO-HER2@kumc.edu for enrollment information.
Where is the NCT06603597 trial being conducted?
This trial is being conducted at Overland Park, United States, Overland Park, United States, Westwood, United States, Westwood, United States and 2 additional locations.
Who is sponsoring the NCT06603597 clinical trial?
NCT06603597 is sponsored by Priyanka Sharma. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.